We next examined how candidate proteins related to plasma biomarkers of AD pathology (Aβ42/40 ratio, pTau-181) and neurodegeneration (GFAP, NfL) using data from the BLSA and the ARIC study. This evidence concerns the gene NEFL and Alzheimer disease.